A Comprehensive Investigation on Common Polymorphisms in the MDR1/ABCB1 Transporter Gene and Susceptibility to Colorectal Cancer

ATP Binding Cassette B1 (ABCB1) is a transporter with a broad substrate specificity involved in the elimination of several carcinogens from the gut. Several polymorphic variants within the ABCB1 gene have been reported as modulators of ABCB1-mediated transport. We investigated the impact of ABCB1 genetic variants on colorectal cancer (CRC) risk. A hybrid tagging/functional approach was performed to select 28 single nucleotide polymorphisms (SNPs) that were genotyped in 1,321 Czech subjects, 699 CRC cases and 622 controls. In addition, six potentially functional SNPs were genotyped in 3,662 German subjects, 1,809 cases and 1,853 controls from the DACHS study. We found that three functional SNPs (rs1202168, rs1045642 and rs868755) were associated with CRC risk in the German population. Carriers of the rs1202168_T and rs868755_T alleles had an increased risk for CRC (Ptrend = 0.016 and 0.029, respectively), while individuals bearing the rs1045642_C allele showed a decreased risk of CRC (Ptrend = 0.022). We sought to replicate the most significant results in an independent case-control study of 3,803 subjects, 2,169 cases and 1,634 controls carried out in the North of Germany. None of the SNPs tested were significantly associated with CRC risk in the replication study. In conclusion, in this study of about 8,800 individuals we show that ABCB1 gene polymorphisms play at best a minor role in the susceptibility to CRC.

[1]  E. Guinó,et al.  Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. , 2011, Mutation research.

[2]  Pavel Soucek,et al.  Variation in the Vitamin D Receptor Gene is not Associated with Risk of Colorectal Cancer in the Czech Republic , 2011, Journal of gastrointestinal cancer.

[3]  C. O'Morain,et al.  Ornithine decarboxylase G316A genotype and colorectal cancer risk , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[4]  M. Kloor,et al.  Association Between TAS2R38 Gene Polymorphisms and Colorectal Cancer Risk: A Case-Control Study in Two Independent Populations of Caucasian Origin , 2011, PloS one.

[5]  J. Behravan,et al.  Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population , 2011, Molecular Biology Reports.

[6]  H. Brenner,et al.  Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. , 2011, Endocrine-related cancer.

[7]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[8]  M. Kloor,et al.  Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study , 2010, BMC gastroenterology.

[9]  Michael Krawczak,et al.  Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. , 2010, Carcinogenesis.

[10]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[11]  G. Pasz-Walczak,et al.  ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer , 2010, International Journal of Colorectal Disease.

[12]  K. Hemminki,et al.  A gene-wide investigation on polymorphisms in the taste receptor 2R14 (TAS2R14) and susceptibility to colorectal cancer , 2010, BMC Medical Genetics.

[13]  P. Sonneveld,et al.  Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin , 2010, Annals of Hematology.

[14]  V. Haufroid,et al.  CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation. , 2010, Pharmacogenomics.

[15]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[16]  Vibeke Andersen,et al.  Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study , 2009, BMC Cancer.

[17]  C Schafmayer,et al.  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer , 2009, British Journal of Cancer.

[18]  Bowang Chen,et al.  SNP_tools: A compact tool package for analysis and conversion of genotype data for MS-Excel , 2009, BMC Research Notes.

[19]  Mark Woodward,et al.  The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence , 2009, International journal of cancer.

[20]  G. Pasz-Walczak,et al.  ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer , 2009, International Journal of Colorectal Disease.

[21]  J. Chang-Claude,et al.  Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk , 2009, Breast Cancer Research and Treatment.

[22]  U. Vogel,et al.  The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study , 2009, BMC Medical Genetics.

[23]  C. Atalay,et al.  Role of ABCB1 and ABCC1 Gene Induction on Survival in Locally Advanced Breast Cancer , 2008, Journal of chemotherapy.

[24]  A. De Pellegrin,et al.  ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer. , 2008, Anticancer research.

[25]  Paolo Vineis,et al.  Expectations and challenges stemming from genome-wide association studies. , 2008, Mutagenesis.

[26]  K. Hemminki,et al.  A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer. , 2008, Mutation research.

[27]  K. Byth,et al.  ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy , 2008, Clinical Cancer Research.

[28]  S. Steinberg,et al.  ABCB1 Genetic Variation Influences the Toxicity and Clinical Outcome of Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel , 2008, Clinical Cancer Research.

[29]  A. Yasunaga,et al.  Association of a polymorphism of ABCB1 with obesity in Japanese individuals. , 2008, Genomics.

[30]  Zanke,et al.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 , 2008, Nature Genetics.

[31]  Julian Peto,et al.  A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 , 2008, Nature Genetics.

[32]  D. Campa,et al.  Association of ABCB1/MDR1 and OPRM1 Gene Polymorphisms With Morphine Pain Relief , 2008, Clinical pharmacology and therapeutics.

[33]  F. Pierre,et al.  Experimental Evidence , 2020, Vision and Perception.

[34]  D. Toncheva,et al.  No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients , 2008, Journal of Cancer Research and Clinical Oncology.

[35]  Oliver Sieber,et al.  A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk , 2007, Nature Genetics.

[36]  Chava Kimchi-Sarfaty,et al.  Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. , 2007, Cancer research.

[37]  G. Mann,et al.  Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype , 2007, Clinical pharmacology and therapeutics.

[38]  C. Meisel,et al.  Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers , 2006, European Journal of Clinical Pharmacology.

[39]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  Chang-Shin Park,et al.  Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans , 2006, Cancer science.

[41]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[42]  J Chang-Claude,et al.  Does a negative screening colonoscopy ever need to be repeated? , 2005, Gut.

[43]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[44]  J. Lubiński,et al.  Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients , 2005, European Journal of Clinical Pharmacology.

[45]  H. Drummond,et al.  Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. , 2005, Gastroenterology.

[46]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[47]  D. Glavač,et al.  Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis , 2004, Genes and Immunity.

[48]  W. Młynarski,et al.  Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia , 2004, European journal of haematology.

[49]  D. Nyholt.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[50]  R. O. Oude Elferink,et al.  ABC of oral bioavailability: transporters as gatekeepers in the gut , 2003, Gut.

[51]  Jos H Beijnen,et al.  The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2003, Cancer research.

[52]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[53]  R. Kim,et al.  Identification of functionally variant MDR1 alleles among European Americans and African Americans , 2001, Clinical pharmacology and therapeutics.

[54]  M. Leppert,et al.  Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. , 2000, Journal of the National Cancer Institute.

[55]  U. Brinkmann,et al.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  T. Walle,et al.  Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps. , 1999, Carcinogenesis.

[57]  H K Kroemer,et al.  The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. , 1999, The Journal of clinical investigation.

[58]  W. Wilson,et al.  Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. , 1998, Blood.

[59]  F. Campbell,et al.  Active transport of benzo[a]pyrene in apical membrane vesicles from normal human intestinal epithelium. , 1994, Biochimica et biophysica acta.

[60]  G. C. Yeh,et al.  Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. , 1993, Cancer research.

[61]  G. Thomas,et al.  [Genetic predisposition to colorectal cancer]. , 1993, Annales de gastroenterologie et d'hepatologie.

[62]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Jie Yang,et al.  Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis , 2010, Breast Cancer Research and Treatment.

[64]  K. Matsuo,et al.  Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[65]  U. John,et al.  Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case‐control sample , 2009, International journal of cancer.

[66]  D. Kerr,et al.  Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk , 2008, Nature Genetics.

[67]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[68]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[69]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .